Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Coagulation Factor IX market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Coagulation Factor IXmarket, defines the market attractiveness level of Coagulation Factor IX market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Coagulation Factor IX industry, describes the types of Coagulation Factor IX market, the applications of major players and the market size, and deeply analyzes the current situation of the global Coagulation Factor IX market and the development prospects and opportunities of Coagulation Factor IX industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Coagulation Factor IX market in Chapter 13.
By Player:
Baxter
Novo Nordisk
Pfizer
CSL Behring
Sanquin
Aptevo
Grifols
Shire
Bioverativ
By Type:
Coagulation Factor IX (Plasma Derived)
Coagulation Factor IX (Recombinant)
By End-User:
Adult
Kids
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Coagulation Factor IX Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Coagulation Factor IX Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Coagulation Factor IX Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Coagulation Factor IX Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Coagulation Factor IX Market Analysis and Outlook to 2022
-
7.1 Global Coagulation Factor IX Consumption (2017-2022)
-
7.2 United States Coagulation Factor IX Consumption (2017-2022)
-
7.3 Europe Coagulation Factor IX Consumption (2017-2022)
-
7.4 China Coagulation Factor IX Consumption (2017-2022)
-
7.5 Japan Coagulation Factor IX Consumption (2017-2022)
-
7.6 India Coagulation Factor IX Consumption (2017-2022)
-
7.7 South Korea Coagulation Factor IX Consumption (2017-2022)
8 Region and Country-wise Coagulation Factor IX Market Analysis and Outlook to 2028
-
8.1 Global Coagulation Factor IX Consumption Forecast (2022-2028)
-
8.2 United States Coagulation Factor IX Consumption Forecast (2022-2028)
-
8.3 Europe Coagulation Factor IX Consumption Forecast (2022-2028)
-
8.4 China Coagulation Factor IX Consumption Forecast (2022-2028)
-
8.5 Japan Coagulation Factor IX Consumption Forecast (2022-2028)
-
8.6 India Coagulation Factor IX Consumption Forecast (2022-2028)
-
8.7 South Korea Coagulation Factor IX Consumption Forecast (2022-2028)
9 Global Coagulation Factor IX Market Outlook by Types and Applications to 2022
-
9.1 Global Coagulation Factor IX Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Coagulation Factor IX (Plasma Derived) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Coagulation Factor IX (Recombinant) Consumption and Growth Rate (2017-2022)
-
9.2 Global Coagulation Factor IX Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Adult Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Kids Consumption and Growth Rate (2017-2022)
10 Global Coagulation Factor IX Market Outlook by Types and Applications to 2028
-
10.1 Global Coagulation Factor IX Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Coagulation Factor IX (Plasma Derived) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Coagulation Factor IX (Recombinant) Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Coagulation Factor IX Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Adult Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Kids Consumption Forecast and Growth Rate (2022-2028)
11 Global Coagulation Factor IX Import and Export Analysis (Top 5 Countries)
-
11.1 Global Coagulation Factor IX Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Coagulation Factor IX Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Coagulation Factor IX Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Coagulation Factor IX Market Competitive Analysis
-
14.1 Baxter
-
14.1.1 Baxter Company Details
-
14.1.2 Baxter Coagulation Factor IX Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Baxter Coagulation Factor IX Product and Service
-
14.2 Novo Nordisk
-
14.2.1 Novo Nordisk Company Details
-
14.2.2 Novo Nordisk Coagulation Factor IX Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Novo Nordisk Coagulation Factor IX Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer Coagulation Factor IX Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Coagulation Factor IX Product and Service
-
14.4 CSL Behring
-
14.4.1 CSL Behring Company Details
-
14.4.2 CSL Behring Coagulation Factor IX Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 CSL Behring Coagulation Factor IX Product and Service
-
14.5 Sanquin
-
14.5.1 Sanquin Company Details
-
14.5.2 Sanquin Coagulation Factor IX Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Sanquin Coagulation Factor IX Product and Service
-
14.6 Aptevo
-
14.6.1 Aptevo Company Details
-
14.6.2 Aptevo Coagulation Factor IX Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Aptevo Coagulation Factor IX Product and Service
-
14.7 Grifols
-
14.7.1 Grifols Company Details
-
14.7.2 Grifols Coagulation Factor IX Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Grifols Coagulation Factor IX Product and Service
-
14.8 Shire
-
14.8.1 Shire Company Details
-
14.8.2 Shire Coagulation Factor IX Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Shire Coagulation Factor IX Product and Service
-
14.9 Bioverativ
-
14.9.1 Bioverativ Company Details
-
14.9.2 Bioverativ Coagulation Factor IX Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Bioverativ Coagulation Factor IX Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Coagulation Factor IX
-
Figure Coagulation Factor IX Picture
-
Table Global Coagulation Factor IX Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Coagulation Factor IX Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Coagulation Factor IX Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Coagulation Factor IX Consumption by Country (2017-2022)
-
Figure United States Coagulation Factor IX Consumption and Growth Rate (2017-2022)
-
Table Europe Coagulation Factor IX Consumption and Growth Rate (2017-2022)
-
Figure China Coagulation Factor IX Consumption and Growth Rate (2017-2022)
-
Figure Japan Coagulation Factor IX Consumption and Growth Rate (2017-2022)
-
Figure India Coagulation Factor IX Consumption and Growth Rate (2017-2022)
-
Figure South Korea Coagulation Factor IX Consumption and Growth Rate (2017-2022)
-
Figure Global Coagulation Factor IX Consumption Forecast by Country (2022-2028)
-
Figure United States Coagulation Factor IX Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Coagulation Factor IX Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Coagulation Factor IX Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Coagulation Factor IX Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Coagulation Factor IX Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Coagulation Factor IX Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Coagulation Factor IX (Plasma Derived) Consumption and Growth Rate (2017-2022)
-
Figure Global Coagulation Factor IX (Recombinant) Consumption and Growth Rate (2017-2022)
-
Figure Global Adult Consumption and Growth Rate (2017-2022)
-
Figure Global Kids Consumption and Growth Rate (2017-2022)
-
Figure Global Coagulation Factor IX (Plasma Derived) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Coagulation Factor IX (Recombinant) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Adult Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kids Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Coagulation Factor IX Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Coagulation Factor IX Export by Region (Top 5 Countries) (2017-2028)
-
Table Baxter (Foundation Year, Company Profile and etc.)
-
Table Baxter Coagulation Factor IX Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter Coagulation Factor IX Product and Service
-
Table Novo Nordisk (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk Coagulation Factor IX Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk Coagulation Factor IX Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Coagulation Factor IX Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Coagulation Factor IX Product and Service
-
Table CSL Behring (Foundation Year, Company Profile and etc.)
-
Table CSL Behring Coagulation Factor IX Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Behring Coagulation Factor IX Product and Service
-
Table Sanquin (Foundation Year, Company Profile and etc.)
-
Table Sanquin Coagulation Factor IX Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanquin Coagulation Factor IX Product and Service
-
Table Aptevo (Foundation Year, Company Profile and etc.)
-
Table Aptevo Coagulation Factor IX Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aptevo Coagulation Factor IX Product and Service
-
Table Grifols (Foundation Year, Company Profile and etc.)
-
Table Grifols Coagulation Factor IX Sales, Price, Value and Gross Profit (2017-2022)
-
Table Grifols Coagulation Factor IX Product and Service
-
Table Shire (Foundation Year, Company Profile and etc.)
-
Table Shire Coagulation Factor IX Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Coagulation Factor IX Product and Service
-
Table Bioverativ (Foundation Year, Company Profile and etc.)
-
Table Bioverativ Coagulation Factor IX Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bioverativ Coagulation Factor IX Product and Service
-
